Won Jung Koh

Title: Innovations by Won Jung Koh in Myeloid-Derived Suppressor Cells

Introduction

Won Jung Koh is an accomplished inventor based in Seoul, South Korea. He has made significant contributions to the field of immunology, particularly in the production of myeloid-derived suppressor cells (MDSCs). His innovative methods have the potential to advance therapeutic strategies in various medical applications.

Latest Patents

Won Jung Koh holds a patent titled "Method for producing myeloid-derived suppressor cells, myeloid-derived suppressor cells produced thereby, and methods thereof." This invention relates to a method for inducing differentiation of bone marrow cells into MDSCs by treating the bone marrow cells with a toll-like receptor agonist (TLR agonist) or type I interferon. Additionally, it includes methods for inducing dendritic cells from the MDSCs. He has 1 patent to his name.

Career Highlights

Throughout his career, Won Jung Koh has worked with prestigious institutions such as Yonsei University and Sungkyunkwan University. His research has focused on the mechanisms of immune regulation and the therapeutic potential of MDSCs in cancer and other diseases.

Collaborations

Some of his notable coworkers include Sung Jae Shin and Woo Sik Kim. Their collaborative efforts have contributed to advancing research in the field of immunology.

Conclusion

Won Jung Koh's innovative work in the production of myeloid-derived suppressor cells showcases his commitment to advancing medical science. His contributions have the potential to impact therapeutic approaches in immunology significantly.